CAS 1173111-67-5

Fórmula: C26H34F3N5O7S

InChI: InChI=1S/C25H30F3N5O4.CH4O3S/c1-24(2)10-18-21(19(34)11-24)22(25(26,27)28)32-33(18)14-5-8-16(23(30)36)17(9-14)31-13-3-6-15(7-4-13)37-20(35)12-29;1-5(2,3)4/h5,8-9,13,15,31H,3-4,6-7,10-12,29H2,1-2H3,(H2,30,36);1H3,(H,2,3,4)

Chave InChI: NVGFSTMGRRADRG-UHFFFAOYSA-N

SMILES: CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)OC(=O)CN)C(F)(F)F)C.CS(=O)(=O)O

PF-04929113 Mesylate

CAS: 1173111-67-5

PF-04929113 Mesylate

Fórmula: C₂₆H₃₄F₃N₅O₇S

Pureza: ≥98%

Peso molecular: 617.63

Ref: 54-BUP09610

PF-04929113 Mesylate

CAS: 1173111-67-5

Fórmula: C₂₆H₃₄F₃N₅O₇S

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 617.6377

Ref: IN-DA008TPB

PF-04929113 Mesylate

CAS: 1173111-67-5

PF-04929113 Mesylate (SNX-5422 Mesylate), a prodrug of SNX-2112, is an orally available Hsp90 inhibitor (Kd: 41 nM) and also induces Her-2 degradation (IC50: 37

Fórmula: C₂₆H₃₄F₃N₅O₇S

Pureza: 99% - 99.46%

Cor e Forma: Solid

Peso molecular: 617.638

Ref: TM-T4342

PF-04929113 (Mesylate)

CAS: 1173111-67-5

PF-04929113 (Mesylate) is a small molecule inhibitor, which is derived from synthetic sources, designed to target the phosphoinositide 3-kinase (PI3K) pathway with high specificity and potency. This compound exerts its mode of action through the inhibition of PI3K activity, a pivotal signaling molecule involved in multiple cell processes including growth, metabolism, and survival. By blocking PI3K, PF-04929113 disrupts downstream signaling pathways, leading to reduced cellular proliferation and inducing apoptosis in cancer cells.

Fórmula: C₂₅H₃₀F₃N₅O₄•CH₄O₃S

Pureza: Min. 95%

Peso molecular: 521.54 g/mol

Ref: 3D-YWB11167